Evidence map›Paper›PMID 41141548›Full record

ArticleEuropean heart journal. Case reports2025

Heart as white as stone, reborn: an unusual case report of idiopathic myocardial calcifications leading to end-stage heart failure and cardiac transplantation.

Alexander Fardman, Yael Peled, Orly Goitein, Shira Goldenberg, Roy Beigel

Abstract readCase Reports
In one paragraph

Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander FardmanDepartment of Cardiology, The Heart Center, Sheba Medical Center, Tel Hashomer, Ramat-Gan 5262000, Israel.ORCID https://orcid.org/0000-0003-4541-8366
Yael PeledDepartment of Cardiology, The Heart Center, Sheba Medical Center, Tel Hashomer, Ramat-Gan 5262000, Israel.
Orly GoiteinDiagnostic Radiology, Sheba Medical Center, Tel Hashomer, Ramat-Gan 5262000, Israel.ORCID https://orcid.org/0000-0003-2027-874X
Shira GoldenbergDepartment of Family Medicine, Maccabi Health Services, Ahuza Street, Raanana 4345020, Israel.
Roy BeigelDepartment of Cardiology, The Heart Center, Sheba Medical Center, Tel Hashomer, Ramat-Gan 5262000, Israel.ORCID https://orcid.org/0009-0003-0600-7692

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Massive myocardial calcifications without an underlying cause are a rare entity of unknown pathophysiology that could result in heart failure with preserved ejection fraction and restrictive physiology. The role of heart transplantation in these cases is unclear due to a lack of data and a concern that calcifications could reoccur in a transplanted organ. Case summary: We describe herein a 61-year-old patient who presented with new-onset heart failure with preserved ejection fraction. Multimodality imaging evaluation was consistent with restrictive cardiomyopathy secondary to massive myocardial calcifications. Extensive workup did not detect an underlying aetiology that could lead to development of myocardial calcifications. Eventually, at the age of 66, the patient underwent successful heart transplantation without evidence of calcification recurrence during a long-term follow-up of 9 years. Conclusion: Massive myocardial calcifications could result in end-stage heart failure. Heart transplantation might be considered a safe and reasonable therapeutic option in patients with idiopathic myocardial calcifications.

Indexed as

Case reportHeart failureHeart transplantationMyocardial calcifications

Identifiers

PMID41141548
PMCPMC12550892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.